Search clinical trials for: zone-Model Predictive Control algorithm
Total 0 results
Nothing found
Sponsors and Collaborators
- Fondation Leenaards, Switzerland
- The Dentist
- Pedro Julian Flores Moreno
- Dalian Hospital of Chinese Traditional and Western Medicine
- The PepsiCo Foundation
- Organkirurgisk afdeling, sygehus lillebælt, Kolding
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- Legal and General
- Pharma Valley Center
- Tecnalia
- Benazzouz Redouene Sid Ahmed
- Ospedale Garibaldi, Catania
- xiaojing wang
- Honda R&D Americas, Inc
- Mahavir Hospital and Research Centre, Hyderabad
- SO Riabilitazione Neuromotoria, IRCCS Fondazione Don Carlo Gnocchi (Firenze) - Francesca Cecchi
- Sonoma Department of Public Health
- Roche Diabetes Care Deutschland GmbH
- Fidmi Medical
- Xinchen Wang
- View Full List
Medical Conditions
- Foeniculum
- Progressive IgA Nephropathy
- Combat Posttraumatic Stess Disorder
- KRAS Mutant Metastatic Non-small Cell Lung Cancer
- Neoplasms, Cystic, Mucinous, and Serous
- Other Complications
- Hair Graying
- Postoperative Wound Healing
- Non-Small Cell Lung Cancer ALK-positive
- Aminoglycoside Toxicity
- Recurrent Pericarditis
- Marrow Toxic Injury
- Nurse
- Active Cancer Treatment
- Unstable Cervical Injury
- Osteoarthropathy
- Uterine Hyperstimulation
- Oculo-Auriculo-Vertebral-Syndrome
- Immediate Temporization and Soft Tissue Augmentation Around Delayed Implants
- Anxiety Disorder, Unspecified
- View Full List
Drug Interventions
- Mild dose cannabis
- Anlotinib Hydrochloride
- Chloroquine- P. vivax
- Bevacizumab [Avastin]
- Vismodegib
- Tavanic
- Insulin Lispro
- Ropivacaine Intermittent Bolus
- Alteplase
- ShA9 Topical Gel
- Intravenous immunoglobulin therapy
- HRS-2329 Tablet
- DE-104 ophthalmic solution, high concentration
- GSK1265744 LAP 800mg intramuscular injection
- Sufentanil + nalbuphine
- 0.04 mg/kg of DGPR1008 Injection was administered 24 hours before surgery
- SPARC1028
- Surgilube
- Letermovir 240 mg Oral Tablet
- Pediatric-type of chemotherapy (+blinatumomab for B-cell precursor ALL)
- View Full List
CROs by country
- Contract Research Organizations in Colombia
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Ecuador
- Contract Research Organizations in France
- Contract Research Organizations in India
- Contract Research Organizations in Iran
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Suriname
- Contract Research Organizations in United States
- Contract Research Organizations in Zambia
- CRO list by country